InsiderTrades.com logo
The only candlestick pattern worth a darn
From WealthPress   |   Ad
It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…
Follow this link here and enter your email address to sign up…

CATX Insider Trading

Insider Ownership Percentage: 3.52%
Insider Buying (Last 12 Months): $58,050,439.60
Insider Selling (Last 12 Months): $0.00

Perspective Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Perspective Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perspective Therapeutics Share Price & Price History

Current Price: $7.88
Price Change: ▼ Price Decrease of -1.04 (-11.66%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for CATX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Strange: Why is Amazon suddenly yielding 39.70%?
From Investors Alley   |   Ad
Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!
Click here to see this breakthrough before everyone else →

Perspective Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/17/2024Jonathan Robert HuntCFOBuy1,800$9.81$17,658.0035,971View SEC Filing Icon  
6/14/2024Lori A WoodsDirectorBuy4,587$10.90$49,998.30159,985View SEC Filing Icon  
6/13/2024Johan M SpoorCEOBuy10,000$11.70$117,000.0013,757View SEC Filing Icon  
6/3/2024Lori A WoodsDirectorBuy3,424$14.60$49,990.40155,398View SEC Filing Icon  
5/31/2024Jonathan Robert HuntCFOBuy2,500$14.00$35,000.0034,171View SEC Filing Icon  
5/31/2024Robert F Williamson IIIDirectorBuy5,500$13.80$75,900.0042,379View SEC Filing Icon  
5/29/2024Robert F Williamson IIIDirectorBuy3,003$13.30$39,939.9036,879View SEC Filing Icon  
3/6/2024Lantheus Alpha Therapy, LlcMajor ShareholderBuy6,043,103$9.50$57,409,478.5011,677,339View SEC Filing Icon  
1/29/2024Robert F Williamson IIIDirectorBuy2,526$6.40$16,166.4021,155View SEC Filing Icon  
1/25/2024Robert F Williamson IIIDirectorBuy2,213$4.90$10,843.707,567View SEC Filing Icon  
1/24/2024Markus PuhlmannInsiderBuy28,000$5.00$140,000.00137,542View SEC Filing Icon  
12/21/2023Robert F Williamson IIIDirectorBuy366$3.30$1,207.80366View SEC Filing Icon  
12/18/2023Jonathan Robert HuntCFOBuy12,500$2.60$32,500.0031,671View SEC Filing Icon  
12/18/2023Markus PuhlmannInsiderBuy6,041$2.60$15,706.6069,542View SEC Filing Icon  
12/18/2023Robert F Williamson IIIDirectorBuy1,000$2.60$2,600.001,000View SEC Filing Icon  
12/15/2023Markus PuhlmannInsiderBuy13,500$2.70$36,450.0063,500View SEC Filing Icon  
See Full Table
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

SEC Filings (Institutional Ownership Changes) for Perspective Therapeutics (NYSE:CATX)

54.66% of Perspective Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CATX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Perspective Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC1,164,204$15.55M0.0%+12.5%1.722%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC114,075$1.52M0.0%+587.9%0.169%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd37,300$0.50M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC25,256$0.34M0.0%-67.9%0.037%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.589,295$7.87M1.3%-25.1%0.872%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,190,239$29.24M0.0%+119.6%3.240%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC4,799,352$64.01M0.0%+8.0%7.101%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC138,350$1.85M0.6%+21.8%0.205%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC28,723$0.38M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC18,117$0.24M0.0%-96.5%0.027%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC58,678$0.78M0.0%+5.8%0.087%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 11,378$0.15M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC341,739$4.56M2.4%-13.8%0.507%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC31,165$0.42M0.0%+159.1%0.046%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets47,565$0.64M0.0%+1,302.7%0.071%Search for SEC Filing on Google Icon
11/13/2024FMR LLC5,504,822$73.49M0.0%+3,994.9%8.164%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 20,514$0.27M0.0%+8.9%0.030%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.181,467$2.42M0.0%-24.9%0.269%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.433,522$5.79M0.0%+221.7%0.643%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC10,289$0.14M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP30,000$0.40M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/6/2024RIA Advisory Group LLC25,620$0.34M0.1%N/A0.038%Search for SEC Filing on Google Icon
11/6/2024CIBC Asset Management Inc19,415$0.26M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.50,460$0.67M0.0%+328.7%0.075%Search for SEC Filing on Google Icon
11/5/2024WealthPlan Investment Management LLC339,292$4.53M0.5%N/A0.503%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC11,424$0.15M0.0%N/A0.017%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC80,000$1.07M0.8%-2.4%0.128%Search for SEC Filing on Google Icon
10/28/2024Hills Bank & Trust Co1,027,830$13.72M1.0%N/A1.651%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE6,576$88K0.0%+142.7%0.011%Search for SEC Filing on Google Icon
10/24/2024Taylor & Morgan Wealth Management LLC30,000$0.40M0.3%N/A0.048%Search for SEC Filing on Google Icon
10/23/2024Trueblood Wealth Management LLC16,236$0.22M0.1%N/A0.026%Search for SEC Filing on Google Icon
10/23/2024Nicholson Wealth Management Group LLC1,602,283$21.39M17.6%N/A2.573%Search for SEC Filing on Google Icon
10/21/2024Wealth Effects LLC13,250$0.18M0.1%-23.6%0.021%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC4,300$57K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/11/2024Creative Planning41,175$0.55M0.0%+135.0%0.061%Search for SEC Filing on Google Icon
10/9/2024Iowa State Bank19,061$0.25M0.1%N/A0.031%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC18,461$0.25M0.0%N/A0.030%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd11,842$0.12M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.202,572$2.02M0.0%-98.5%0.325%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company18,842$0.19M0.0%N/A0.030%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C2,817,763$28.09M0.5%-90.0%4.526%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC550,000$5.48M0.6%-89.2%0.883%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd11,842$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,283,942$12.80M0.0%-93.2%2.062%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC396,242$3.95M2.4%N/A0.636%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC113,550$1.13M0.4%N/A0.182%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.132,089$1.32M0.1%-69.3%0.212%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC61,660$0.62M0.0%+94.2%0.099%Search for SEC Filing on Google Icon
8/9/2024WealthPLAN Partners LLC169,963$1.70M0.2%N/A0.273%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd84,363$0.84M0.1%N/A0.135%Search for SEC Filing on Google Icon
8/8/2024Sykon Capital LLC37,932$0.38M0.1%+4.7%0.061%Search for SEC Filing on Google Icon
8/7/2024ClariVest Asset Management LLC54,199$0.54M0.1%N/A0.087%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.11,770$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/2/2024Wealth Effects LLC17,350$0.17M0.1%-85.2%0.028%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers63,170$0.63M0.0%N/A0.101%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp137,268$1.37M0.0%+214.0%0.220%Search for SEC Filing on Google Icon
7/26/2024AlphaCentric Advisors LLC82,000$0.82M0.6%-95.3%0.132%Search for SEC Filing on Google Icon
7/25/2024AMG National Trust Bank37,330$0.37M0.0%-90.0%0.060%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC115,762$0.14M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC13,089,476$15.51M0.0%N/A2.230%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP149,787$0.18M0.0%-98.0%0.026%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC5,100,000$6.07M0.8%N/A0.869%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.17,780,106$21.16M0.0%+34.6%3.029%Search for SEC Filing on Google Icon
5/8/2024Bleakley Financial Group LLC33,570$40K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/3/2024RIA Advisory Group LLC106,853$0.13M0.1%+1,313.4%0.018%Search for SEC Filing on Google Icon
4/26/2024ZWJ Investment Counsel Inc.22,000$26K0.0%N/A0.004%Search for SEC Filing on Google Icon
4/24/2024Simplicity Wealth LLC33,570$40K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/22/2024Perkins Capital Management Inc.700,000$0.28M0.2%-73.8%0.249%Search for SEC Filing on Google Icon
1/11/2024Taylor & Morgan Wealth Management LLC625,000$0.25M0.2%+8.7%0.223%Search for SEC Filing on Google Icon
11/8/2023HighTower Advisors LLC1,147,038$0.31M0.0%N/A0.409%Search for SEC Filing on Google Icon
11/2/2023Perkins Capital Management Inc.2,671,644$0.73M0.7%N/A0.952%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp154,238$42K0.0%N/A0.055%Search for SEC Filing on Google Icon
10/16/2023Wealth Effects LLC110,000$30K0.0%N/A0.039%Search for SEC Filing on Google Icon
10/5/2023Taylor & Morgan Wealth Management LLC575,000$0.16M0.1%N/A0.205%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Perspective Therapeutics logo
Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Read More on Perspective Therapeutics

Today's Range

Now: $7.88
Low: $7.87
High: $8.93

50 Day Range

MA: $12.55
Low: $7.88
High: $15.84

52 Week Range

Now: $7.88
Low: $2.28
High: $19.05

Volume

1,849,338 shs

Average Volume

665,308 shs

Market Capitalization

$532.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46

Who are the company insiders with the largest holdings of Perspective Therapeutics?

Perspective Therapeutics' top insider shareholders include:
  1. Lantheus Alpha Therapy, Llc (Major Shareholder)
  2. Lori A Woods (Director)
  3. Markus Puhlmann (Insider)
  4. Robert F Williamson III (Director)
  5. Jonathan Robert Hunt (CFO)
  6. Johan M Spoor (CEO)
Learn More about top insider investors at Perspective Therapeutics.

Who are the major institutional investors of Perspective Therapeutics?

Perspective Therapeutics' top institutional investors include:
  1. FMR LLC — 8.16%
  2. Janus Henderson Group PLC — 7.10%
  3. State Street Corp — 3.24%
  4. Nicholson Wealth Management Group LLC — 2.57%
  5. Geode Capital Management LLC — 1.72%
  6. Hills Bank & Trust Co — 1.65%
Learn More about top institutional investors of Perspective Therapeutics stock.

Which major investors are selling Perspective Therapeutics stock?

Within the previous quarter, CATX stock was sold by these institutional investors:
  1. Walleye Capital LLC
  2. Sphera Funds Management LTD.
  3. Eagle Asset Management Inc.
  4. Ally Bridge Group NY LLC
  5. Jane Street Group LLC
  6. Wealth Effects LLC
  7. AlphaCentric Advisors LLC

Which major investors are buying Perspective Therapeutics stock?

Within the previous quarter, CATX stock was acquired by institutional investors including:
  1. FMR LLC
  2. Nicholson Wealth Management Group LLC
  3. State Street Corp
  4. Hills Bank & Trust Co
  5. Janus Henderson Group PLC
  6. WealthPlan Investment Management LLC
  7. Charles Schwab Investment Management Inc.
  8. Geode Capital Management LLC
Within the previous year, these company insiders have bought Perspective Therapeutics stock:
  1. Lantheus Alpha Therapy, Llc (Major Shareholder)
  2. Lori A Woods (Director)
  3. Markus Puhlmann (Insider)
  4. Robert F Williamson III (Director)
  5. Jonathan Robert Hunt (CFO)
  6. Johan M Spoor (CEO)
Learn More investors buying Perspective Therapeutics stock.
The only candlestick pattern worth a darn
From WealthPress   |   Ad
It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…
Follow this link here and enter your email address to sign up…